论文部分内容阅读
目的探讨单纯子宫腺肌病病灶切除术后联合促性腺激素释放激素激动剂治疗子宫腺肌病的临床疗效。方法 120例子宫腺肌病患者,以治疗方式的不同将所有研究对象分为观察组和对照组,每组60例,采用单纯子宫腺肌病病灶切除术治疗对照组研究对象,采用单纯子宫腺肌病病灶切除术后联合促性腺激素释放激素激动剂治疗观察组研究对象,比较两组研究对象的临床疗效。结果两组研究对象的治疗总有效率、复发率及治疗后痛经视觉模拟评分比较差异有统计学意义(P<0.05)。结论给予子宫腺肌病患者单纯子宫腺肌病病灶切除术后联合促性腺激素释放激素激动剂治疗可有效的提高治疗效果,减少复发,值得进一步推广应用。
Objective To investigate the clinical efficacy of combined gonadotropin-releasing hormone agonist in the treatment of adenomyosis after focal resection of adenomyosis. Methods A total of 120 patients with adenomyosis were divided into observation group and control group according to the different treatment methods. Each group consisted of 60 patients. The study group was treated with resection of adenomyosis alone, Myopathy after focal resection combined with gonadotropin-releasing hormone agonist treatment group observation object, the clinical efficacy of the two groups were compared. Results The total effective rate of treatment, relapse rate and post-treatment dysmenorrhea visual analog scale scores were statistically significant difference (P <0.05). Conclusion Adenomyosis patients with adenomyosis resection combined with gonadotropin-releasing hormone agonist therapy can effectively improve the treatment effect and reduce recurrence, it is worth further promotion and application.